Reflow Medical, Inc. announced the enrollment of the first patient in the DEEPER CHALLENGE clinical trial, which is investigating e ...

StarMed America announced FDA 510(k) clearance for its radiofrequency ablation (RFA) devices for the treatment of thyroid ...

Nectero Therapeutics announced the 2-year findings from a first-in-human (FIH) multicenter study evaluating treatment of small- to ...

GE HealthCare announced the introduction of Allia platform upgrade pathways that are designed to help customers modernize select l ...

Penumbra Inc. announced it has received CE Mark approval for its Red 72 Silver Label and Red 72 Silver Label with SendIt technolog ...

Artivion, Inc. announced that the FDA has approved the company’s AMDS hybrid prosthesis, an aortic arch remodeling device fo ...

The European Society of Vascular Surgery (ESVS) announced the publication of a focused update on the ESVS peripheral artery ...

Access Vascular, Inc. (AVI) and Medline announced a multiyear agreement to accelerate the rollout of AVI’s next-generation c ...

Johnson & Johnson announced the initiation of its SKYWARD investigational device exemption (IDE) clinical program evaluating t ...

CereVasc, Inc. announced it has completed patient enrollment in the STRIDE pivotal trial, which is evaluating the company’s ...

Route 92 Medical, Inc. announced that the first commercial cases in Canada were performed with the company’s neurovascular d ...